137 related articles for article (PubMed ID: 31613009)
1. NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
Ge F; Zhang P; Niu J; Pei X; Lian C; Yu R; Ma R; Zhang Y; Zhu Z; Sun K
J Cell Physiol; 2020 Apr; 235(4):3790-3797. PubMed ID: 31613009
[TBL] [Abstract][Full Text] [Related]
2. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
4. A large-scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma.
Wei Z; Wu B; Wang L; Zhang J
J Cell Physiol; 2020 Mar; 235(3):2582-2589. PubMed ID: 31490025
[TBL] [Abstract][Full Text] [Related]
5. Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
Zhang H; Song G; Song G; Li R; Gao M; Ye L; Zhang C
PLoS One; 2018; 13(6):e0199689. PubMed ID: 29933410
[TBL] [Abstract][Full Text] [Related]
6. Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia.
Huang J; Liu Z; Sun Y; Zhong Q; Xu L; Ou R; Li C; Chen R; Yao M; Zhang Q; Liu S
Int J Mol Med; 2018 Feb; 41(2):679-686. PubMed ID: 29207054
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive DNA Methylation-transcriptome Profiles Association Analysis During the Treatment of Acute Myelocytic Leukemia.
Wu J; Song MZ; Deng LJ; Ye QL
Curr Pharm Des; 2021; 27(24):2817-2826. PubMed ID: 34082677
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
10. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract][Full Text] [Related]
11. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
[TBL] [Abstract][Full Text] [Related]
14. Region-Specific Methylation Profiling in Acute Myeloid Leukemia.
Cecotka A; Polanska J
Interdiscip Sci; 2018 Mar; 10(1):33-42. PubMed ID: 29405013
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of SRY-box containing gene family member
Zhou JD; Wang YX; Zhang TJ; Li XX; Gu Y; Zhang W; Ma JC; Lin J; Qian J
Clin Epigenetics; 2018; 10():92. PubMed ID: 30002740
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.
Gao H; He X; Li Q; Wang Y; Tian Y; Chen X; Wang J; Guo Y; Wang W; Li X
Cancer Med; 2020 Sep; 9(17):6296-6305. PubMed ID: 32628355
[TBL] [Abstract][Full Text] [Related]
17. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract][Full Text] [Related]
18. A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.
Chen Y; Hei N; Zhao J; Peng S; Yang K; Chen H; Cui Z; Jin L; Sun R; Guo J
J Cell Biochem; 2019 Jun; 120(6):9082-9090. PubMed ID: 30548666
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features.
Jian J; Yuan C; Ji C; Hao H; Lu F
Clin Exp Med; 2023 Oct; 23(6):2639-2649. PubMed ID: 36645547
[TBL] [Abstract][Full Text] [Related]
20. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
